Indeed, while BCAA-induced activation of the mammalian target of rapamycin (mTOR) in skeletal myocytes may contrast sarcopenia and functional decline in advanced age [20,31], other studies found an association between higher circulating levels of BCAAs and insulin resistance or T2DM in older adults [24,25,26,27]. The gene discussed is MTOR; the disease is sarcopenia.